Qsymia is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Vivus, Inc.. The primary component is Phentermine Hydrochloride; Topiramate.
Product ID | 62541-204_7abbdebd-dd3f-53ba-e053-2a91aa0adbbf |
NDC | 62541-204 |
Product Type | Human Prescription Drug |
Proprietary Name | Qsymia |
Generic Name | Phentermine And Topiramate |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2012-09-17 |
Marketing Category | NDA / NDA |
Application Number | NDA022580 |
Labeler Name | Vivus, Inc. |
Substance Name | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
Active Ingredient Strength | 15 mg/1; mg/1 |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-09-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022580 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-09-17 |
Ingredient | Strength |
---|---|
PHENTERMINE HYDROCHLORIDE | 15 mg/1 |
SPL SET ID: | 40dd5602-53da-45ac-bb4b-15789aba40f9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62541-201 | Qsymia | phentermine and topiramate |
62541-202 | Qsymia | phentermine and topiramate |
62541-203 | Qsymia | phentermine and topiramate |
62541-204 | Qsymia | phentermine and topiramate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
QSYMIA 85656775 4295224 Live/Registered |
Vivus, Inc. 2012-06-20 |